Pre-eclampsia: pathogenesis, novel diagnostics and therapies

EA Phipps, R Thadhani, T Benzing… - Nature Reviews …, 2019 - nature.com
Pre-eclampsia is a complication of pregnancy that is associated with substantial maternal
and fetal morbidity and mortality. The disease presents with new-onset hypertension and …

[HTML][HTML] Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta

MK Jena, NR Sharma, M Petitt, D Maulik, NR Nayak - Biomolecules, 2020 - mdpi.com
Preeclampsia (PE) is a serious pregnancy complication, affecting about 5–7% of
pregnancies worldwide and is characterized by hypertension and damage to multiple …

Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial

MM Costantine, K Cleary, MF Hebert, MS Ahmed… - American journal of …, 2016 - Elsevier
Background Preeclampsia complicates approximately 3–5% of pregnancies and remains a
major cause of maternal and neonatal morbidity and mortality. It shares pathogenic …

Molecular mechanisms of preeclampsia

T Hod, AS Cerdeira… - Cold Spring …, 2015 - perspectivesinmedicine.cshlp.org
Preeclampsia is a pregnancy-specific disease characterized by new onset hypertension and
proteinuria after 20 wk of gestation. It is a leading cause of maternal and fetal morbidity and …

Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia

DA Shah, RA Khalil - Biochemical pharmacology, 2015 - Elsevier
Preeclampsia is a pregnancy-associated disorder characterized by hypertension, and could
lead to maternal and fetal morbidity and mortality; however, the pathophysiological …

[HTML][HTML] Testing of drugs using human feto-maternal interface organ-on-chips provide insights into pharmacokinetics and efficacy

LS Richardson, AK Kammala, MM Costantine… - Lab on a Chip, 2022 - pubs.rsc.org
Objectives: To improve preclinical drug testing during pregnancy, we developed multiple
microfluidic organ-on-chip (OOC) devices that represent the structure, functions, and …

The role of statins in the prevention of preeclampsia

DD Smith, MM Costantine - American journal of obstetrics and gynecology, 2022 - Elsevier
Preeclampsia is a common hypertensive disorder of pregnancy associated with
considerable neonatal and maternal morbidities and mortalities. However, the exact cause …

Animal models of preeclampsia: causes, consequences, and interventions

KL Gatford, PH Andraweera, CT Roberts, AS Care - Hypertension, 2020 - Am Heart Assoc
Preeclampsia is a common pregnancy complication, affecting 2% to 8% of pregnancies
worldwide, and is an important cause of both maternal and fetal morbidity and mortality …

Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman primates

A Makris, KR Yeung, SM Lim, N Sunderland… - …, 2016 - Am Heart Assoc
An imbalance in the angiogenesis axis during pregnancy manifests as clinical preeclampsia
because of endothelial dysfunction. Circulating soluble fms-like tyrosine kinase 1 (sFLT-1) …

Novel interventions for the prevention of preeclampsia

M Ma'ayeh, KM Rood, D Kniss… - Current hypertension …, 2020 - Springer
Abstract Purpose of Review To review the rationale and biological plausibility and discuss
the current research on novel interventions for the prevention of preeclampsia. Recent …